At this time, trials and plans for its other CD19 -
directed chimeric antigen receptor (CAR) T - cell product candidates, including JCAR017, are not affected.
JCAR015 is a CD19 -
directed chimeric antigen receptor technology (CAR - T) product candidate that has been under study in ROCKET in adult patients with relapsed or refractory B - cell acute lymphoblastic leukemia.
Not exact matches
Here, we show that in the antibody - mediated autoimmune disease pemphigus vulgaris (PV), autoantigen - based
chimeric immunoreceptors can
direct T cells to kill autoreactive B lymphocytes through the specificity of the B cell receptor (BCR).